Skip to content

✅ Worldwide Shipping

✅ 100% Satisfaction

✅ Cruelty Free

✅ Worldwide Shipping

✅ 100% Satisfaction

✅ Cruelty Free

✅ Worldwide Shipping

✅ 100% Satisfaction

✅ Cruelty Free

✅ Worldwide Shipping

✅ 100% Satisfaction

✅ Cruelty Free

✅ Worldwide Shipping

✅ 100% Satisfaction

✅ Cruelty Free

✅ Worldwide Shipping

✅ 100% Satisfaction

✅ Cruelty Free

✅ Worldwide Shipping

✅ 100% Satisfaction

✅ Cruelty Free

✅ Worldwide Shipping

✅ 100% Satisfaction

✅ Cruelty Free

✅ Worldwide Shipping

✅ 100% Satisfaction

✅ Cruelty Free

✅ Worldwide Shipping

✅ 100% Satisfaction

✅ Cruelty Free

✅ Worldwide Shipping

✅ 100% Satisfaction

✅ Cruelty Free

✅ Worldwide Shipping

✅ 100% Satisfaction

✅ Cruelty Free

PATCH™

See your potential weight loss Determine how much weight you may lose with WW&Napharm®

Average weight loss with WW&Napharm® in a medical study:

In a 12-week medical study of 1,961 adults* living with obesity or overweight with a related medical problem along with reduced-calorie diet and increased physical activity:

On average lost  ~35 LBS
People taking placebo (not on medicine) lost an average of ~2.5% body weight (or about 6 lb)
Average starting weight in both groups: ~232 lb
 

In addition to a reduced-calorie diet and increased physical activity, people in this study taking WW&Napharm® lost more weight vs placebo.

  • of adults taking WW&Napharm® lost 5% or more weight, compared to 31% taking placebo

  • of adults taking WW&Napharm® lost 10% or more weight, compared to 12% taking placebo

  • of adults taking WW&Napharm® lost 15% or more weight, compared to 5% taking placebo

In the same study, some people lost even more weight

30% of people taking WW&Napharm® lost 20% or more weight, compared to 2% of people taking placebo, in a supportive measure. This result was not the primary goal of the medical study and should be considered as additional information.

Individual results may vary.

*Results are from a 68-week medical study of adults with obesity (BMI ≥30) and adults with overweight (BMI ≥27) who also had weight-related medical problems including high blood pressure or high cholesterol. People with type 2 diabetes were excluded. Both groups received instruction for a reduced-calorie diet and increased physical activity. During the trial, 17% of participants taking WW&Napharm® discontinued treatment compared with 22% taking placebo.

 
See the potential weight loss you could experience with WW&Napharm® along with a reduced-calorie diet and increased physical activity.

Discover your potential weight loss with WW&Napharm®

Enter your current

weight above to get

started. Individual results may vary.

Talk to your health care professional about a goal weight that is healthy and realistic for you.

Health care professionals prescribe WW&Napharm® to help with losing weight and keeping it off in adults:
Living with obesity
Living with overweight and weight-related medical problems
 

People who kept taking WW&Napharm® continued to lose weight in a separate 20-week medical study

Everyone started taking WW&Napharm® and were instructed to reduce calories and increase physical activity throughout the length of the study.

After 20 weeks, some people continued to take WW&Napharm®, while others switched to placebo. From weeks 4 to 20, people taking WW&Napharm® continued to lose weight. People taking placebo gained weight.

People taking Wegovy® achieved lasting weight loss in a separate 2-year medical study§

Adults taking WW&Napharm® lost an average of ~15% (~35 lb) vs 2.6% (~6 lb) for adults taking placebo
77% of adults taking WW&Napharm® lost 5% or more weight compared to 34% taking placebo
Average starting weight for people taking WW&Napharm® was ~233 lb and for placebo it was ~235 lb

§This 2-year medical study included 304 adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least 1 weight-related medical condition. People with type 2 diabetes were excluded. Both groups received instruction for a reduced-calorie diet and increased physical activity. During the trial, 13% of participants taking WW&Napharm® discontinued treatment compared with 27% taking placebo.